WO2001041823A8 - Radioactive compositions and methods of use thereof - Google Patents

Radioactive compositions and methods of use thereof

Info

Publication number
WO2001041823A8
WO2001041823A8 PCT/US2000/042577 US0042577W WO0141823A8 WO 2001041823 A8 WO2001041823 A8 WO 2001041823A8 US 0042577 W US0042577 W US 0042577W WO 0141823 A8 WO0141823 A8 WO 0141823A8
Authority
WO
WIPO (PCT)
Prior art keywords
methods
radioactive compositions
radioactive
compositions
Prior art date
Application number
PCT/US2000/042577
Other languages
French (fr)
Other versions
WO2001041823A2 (en
Inventor
Clifford Teoh
Michael P Wallace
Original Assignee
Scimed Life Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems Inc filed Critical Scimed Life Systems Inc
Priority to JP2001543167A priority Critical patent/JP2003522738A/en
Priority to EP00992640A priority patent/EP1301215A1/en
Priority to CA002393539A priority patent/CA2393539A1/en
Publication of WO2001041823A2 publication Critical patent/WO2001041823A2/en
Publication of WO2001041823A8 publication Critical patent/WO2001041823A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/44—Radioisotopes, radionuclides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
PCT/US2000/042577 1999-12-08 2000-12-06 Radioactive compositions and methods of use thereof WO2001041823A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2001543167A JP2003522738A (en) 1999-12-08 2000-12-06 Radioactive compositions and methods of using them
EP00992640A EP1301215A1 (en) 1999-12-08 2000-12-06 Radioactive compositions and methods of use thereof
CA002393539A CA2393539A1 (en) 1999-12-08 2000-12-06 Radioactive compositions and methods of use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/457,227 US6616591B1 (en) 1999-12-08 1999-12-08 Radioactive compositions and methods of use thereof
US09/457,227 1999-12-08

Publications (2)

Publication Number Publication Date
WO2001041823A2 WO2001041823A2 (en) 2001-06-14
WO2001041823A8 true WO2001041823A8 (en) 2002-06-27

Family

ID=23815917

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/042577 WO2001041823A2 (en) 1999-12-08 2000-12-06 Radioactive compositions and methods of use thereof

Country Status (5)

Country Link
US (2) US6616591B1 (en)
EP (1) EP1301215A1 (en)
JP (1) JP2003522738A (en)
CA (1) CA2393539A1 (en)
WO (1) WO2001041823A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US8016852B2 (en) * 1998-11-10 2011-09-13 Stryker Corporation Bioactive components for incorporation with vaso-occlusive members
US6616591B1 (en) * 1999-12-08 2003-09-09 Scimed Life Systems, Inc. Radioactive compositions and methods of use thereof
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20020160034A1 (en) * 2001-02-23 2002-10-31 Luc Levesque Use of occlusion device for the local delivery of biologically active DNA therapeutic compounds for treating aneurysms and use therefor
DE10115740A1 (en) * 2001-03-26 2002-10-02 Ulrich Speck Preparation for restenosis prophylaxis
EP1392182A1 (en) * 2001-05-04 2004-03-03 Concentric Medical Hydrogel vaso-occlusive device
US20030004533A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Bioactive polymer vaso-occlusive device
JP4886939B2 (en) * 2001-07-19 2012-02-29 真也 岡崎 Iodine-releasing therapeutic material and stent for in-vivo placement
CA2460174A1 (en) 2001-09-24 2003-04-03 Novoste Corporation Methods and apparatus employing ionizing radiation for treatment of cardiac arrhythmia
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery
US20100160944A1 (en) * 2008-12-24 2010-06-24 Boston Scientific Scimed, Inc. Thermally detachable embolic assemblies
CN104363922B (en) 2012-06-14 2017-06-30 微仙美国有限公司 Polymer therapeutic combination
AU2013331439B2 (en) 2012-10-15 2016-05-12 Microvention, Inc. Polymeric treatment compositions
JP6373961B2 (en) 2013-03-13 2018-08-15 バイオスフィア メディカル，インコーポレイテッド Composition of radioisotope-binding fine particles and bonding method
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
JP7362598B2 (en) 2017-10-09 2023-10-17 マイクロベンション インコーポレイテッド radioactive liquid embolic material
CN112932585B (en) * 2019-12-11 2023-01-03 先健科技(深圳)有限公司 Left auricle plugging device

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994069A (en) 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5059166A (en) * 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia
DE4104702C2 (en) 1991-02-15 1996-01-18 Malte Neuss Implants for organ pathways in spiral form
EP0791333B1 (en) 1991-12-12 1999-12-01 Target Therapeutics, Inc. Detachable pusher-vasoocclusive coil assembly with interlocking coupling
US5350397A (en) 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5925059A (en) 1993-04-19 1999-07-20 Target Therapeutics, Inc. Detachable embolic coil assembly
US5522836A (en) 1994-06-27 1996-06-04 Target Therapeutics, Inc. Electrolytically severable coil assembly with movable detachment point
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
DE69624525T2 (en) 1995-03-30 2003-03-20 Boston Scient Ltd System for implanting liquid spirals with a secondary structure
US5747637A (en) 1995-09-07 1998-05-05 Mitsui Toatsu Chemicals, Inc. Bioabsorbable polymer and process for preparing the same
US6589502B1 (en) * 1995-11-27 2003-07-08 International Brachytherapy S.A. Radioisotope dispersed in a matrix for brachytherapy
US5658308A (en) 1995-12-04 1997-08-19 Target Therapeutics, Inc. Bioactive occlusion coil
US5749894A (en) 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
JP2000509014A (en) * 1996-03-11 2000-07-18 フォーカル，インコーポレイテッド Polymer delivery of radionuclides and radiopharmaceuticals
US5690667A (en) 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US5871437A (en) * 1996-12-10 1999-02-16 Inflow Dynamics, Inc. Radioactive stent for treating blood vessels to prevent restenosis
US5733329A (en) 1996-12-30 1998-03-31 Target Therapeutics, Inc. Vaso-occlusive coil with conical end
US6106454A (en) * 1997-06-17 2000-08-22 Medtronic, Inc. Medical device for delivering localized radiation
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
CA2326977A1 (en) * 1998-04-03 1999-10-14 Dupont Pharmaceuticals Company Inorganic material for radioactive drug delivery
US6001054A (en) * 1998-05-19 1999-12-14 Regulla; D. F. Method and apparatus for differential energy application for local dose enhancement of ionizing radiation
US6296603B1 (en) * 1998-05-26 2001-10-02 Isostent, Inc. Radioactive intraluminal endovascular prosthesis and method for the treatment of aneurysms
JP2002524108A (en) * 1998-07-28 2002-08-06 インナーダイン， インコーポレイテッド Absorbable brachytherapy and chemotherapy delivery devices and methods
US6379648B1 (en) * 1999-02-01 2002-04-30 The Curators Of The University Of Missouri Biodegradable glass compositions and methods for radiation therapy
US6333020B1 (en) * 1999-05-13 2001-12-25 Micro Therapeutics, Inc. Methods for treating AVM's using radio active compositions
US6616591B1 (en) * 1999-12-08 2003-09-09 Scimed Life Systems, Inc. Radioactive compositions and methods of use thereof

Also Published As

Publication number Publication date
JP2003522738A (en) 2003-07-29
EP1301215A1 (en) 2003-04-16
WO2001041823A2 (en) 2001-06-14
US20030225309A1 (en) 2003-12-04
US6616591B1 (en) 2003-09-09
CA2393539A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2609901A (en) Antimicrobial compositions and methods of use
AUPQ419099A0 (en) Novel compositions and methods
HK1048247A1 (en) Stable carotene-xanthophyll beadlet compositions and methods of use
EP1227821A4 (en) Therapeutic compositions and methods of use thereof
EP1176948A4 (en) Anti-nausea compositions and methods
WO2001041823A8 (en) Radioactive compositions and methods of use thereof
AU5326100A (en) Pharmaceutical compositions and methods for use
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU5565099A (en) Pharmaceutical compositions and methods for use
AU5800399A (en) Polish composition and method of use
AU1403501A (en) Novel composition and use
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AU1152601A (en) Compositions and their use
EP1139981A4 (en) Compositions and methods of using the same
AU2962400A (en) Cleaner composition and method of use thereof
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU3774100A (en) Heat-activated cleaning compositions with wrinkle-resistance and methods of use
AU2221400A (en) Compositions containing and methods of using n-acyl-1h-aminoindenes
AU1459500A (en) Dihydropyridine compounds and methods of use
AU2880699A (en) Pharmaceutical compositions and methods for use
AUPO982097A0 (en) Methods and compositions for use therein
AU5931300A (en) Ringene compositions and methods for use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2393539

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 543167

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000992640

Country of ref document: EP

AK Designated states

Kind code of ref document: C1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

D17 Declaration under article 17(2)a
WWP Wipo information: published in national office

Ref document number: 2000992640

Country of ref document: EP